RAPT Therapeutics, Inc. — Director's Dealing 2021

Jun 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-06-16

Reporting Person: Robbins Wendye (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-16	Common Stock	P	500	$31.54	Acquired	6600	Direct
2021-06-16	Common Stock	P	100	$31.56	Acquired	6700	Direct
2021-06-16	Common Stock	P	100	$31.5299	Acquired	6800	Direct
2021-06-16	Common Stock	P	5	$31.61	Acquired	305	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1300	Indirect